Drug Discovery| Metabolism | Pharmaceutical Development| Toxicology| Analysis

Manufacturing| Information| Regulatory Issues| Databases| Services| BioStocks

DRUG DISCOVERY


Email me!

 

Databases

(Discipline Experts on the NIH / FDA Advisory Committees)

 

(1) Pharmaceutical Science Advisory Committees

Joseph Bloom PhD, University of Puerto Rico

Lemuel Moye MD,PhD, University of Texas Health Science Center at Houston

Arthur Kibbe PhD, Wilkes University

Kathleen Reedy RDH,MS, FDA

Nair Rodrigues-Hornedo PhD, University of Michigan

Marvin Meyer PhD, Boca Raton Florida

Patrick DeLuca PhD, University of Kentucky

 

(2) Dermatologic and Ophthalmic Drugs Advisory Committee

Robert Stern, MD, Beth Israel Deaconess Medical Center

June Lee, MD, PhD, National Institutes of Health

Roselyn Epps, MD, Children's National Medical Center

Lloyd King, MD, PhD, Vanderbilt University

Sharon Raimer MD, University of Texas-Galveston

Karen Templeton-Somers, PhD, FDA

Elizabeth Abel MD, Dermatology Practice Mountain View Calif

Robert Katz, MD, Dermatology Practice Rockville Md

Paula Knudson, University of Texas-Houston

 

(3) Nonclinical Studies Subcommittee

John Doull MD, PhD, University of Kansas Medical Center

Joy Cavagnaro PhD, National Center for Toxicological Research, FDA

James MacGregor PhD, National Center for Toxicological Research, FDA

Gloria Anderson PhD, Morris Brown College

Jay Goodman PhD, Michigan State University

June Lee MD, PhD, National Institutes of Health

David Essayan MD, CBER, FDA

Daniel Casciano PhD, National Center for Toxicological Research, FDA

 

(4) Process Analytical Technologies Subcommittee

Thomas Layloff PhD, Center for Pharmaceutical Management

July Boehlert PhD, Boehlert Associates

Gloria Anderson PhD, Morris Brown College

Joseph Bloom PhD, University of Puerto Rico School of Pharmacy

Arthur Kibbe PhD, Wilkes University

 

(5) Clinical Pharmacology Subcommittee

William Jusko PhD, State University of New York At Buffalo School of Pharmacy

Hartmut Derendorf PhD, University of Florida College of Pharmacy

Mike Hale PhD, Glaxo Smith Kline

Richard Lalonde PharmD, Pfizer

Mary Relling PharmD, St. Jude Children's Research Hospital Lewis Sheiner MD, University of California at San Francisco

Edward Caparelli PharmD, University of California at San Diego

Dave Flockhart MD, PhD, Indian University School of Medicine

Gregory Kearns PharmD, Children's Mercy Hospital

Howard McCleod PharmD, Washington University

Wolfgang Sadee PhD, Ohio State University

Jurgen Venitz MD, PhD, Virginia Commonwealth University School of Pharmacy

 

(6) Orally Inhaled & Nasal Drug Products Subcommittee

Vincent Lee PhD, University of Southern California

Stanley Szefler MD, National Jewish Center Gloria Anderson PhD, Morris Brown College

Guirag Poochikian PhD, (FDA Representative)

James Li MD, PhD, Mayo Clinic Richard Ahrens MD,University of Iowa

Wallace Adams PhD, FDA

 

(7) Endocrinologic and Metabolic Drugs Advisory Committee

Glenn Braunstein MD, Cedars-Sinai Medical Center

Deborah Grady MD,MPH, University of California San Francisco

Lynne Levitsky MD, Harvard University School of Medicine

Kathleen Reedy RDH, MS, FDA

Marie Gelato MD, PhD, SUNY at Stony Brook Health Science Center

William Tamborlane MD, Yale University School of Medicine

Nancy Worcester PhD, University of Wisconsin Madison

 

(8) Antiviral Drugs Advisory Committee

Roy Gulick MD, MPH, Cornell University Weill Medical College

Victor DeGruttola ScD, Harvard School of Public Health

Princy Kumar MD, Georgetown University

Jonathan Schapiro MD, Stanford University

Lauren Wood MD, National Cancer Institute

Tara Turner PharmD, FDA

June Lee, MD, PhD, NIH

Janet Englund MD, University of Chicago

Courtney Fletcher PharmD, University of Colorado

Christopher Mathews MD,MSPH, University of California-San Diego

Sharilyn Stanley MD, Texas Department of Health

 

(9) Reproductive Health Drugs Advisory Committee

Linda Giudice MD,PhD, Stanford University Medical Center

Susan Crockett MD, University of Texas-San Antonio

June Lee MD, PhD, National Institutes of Health

Scott Emerson MD,PhD, University of Washington

David Hager MD, University of Kentucky College of Medicine

George Marcones MD, University of Pennsylvania

Joseph Stanford MD, University of Utah

Jayne Peterson RPh,JD, FDA

Leslie Gay Bernitsky MD, Albuquerque

Nancy Dickey MD, Texax A&M College of Medicine

Michael Greene MD, Massachussetts General Hospital

Vivian Lewis MD, University of Rochester Medical Center

Valerie Rice MD, University of Kansas Medical Center

 

(10) Peripheral and Central Nervous System Drugs Advisory Committee

Claudia Kawas MD, University of California Irvine

LaRoy Penix MD, Morehouse School of Medicine Neuroscience Institute

Michael Grundman MD, MPH, University of California San Diego

Howard Weiner MD, Harvard Medical School Brigham & Women's Hospital

Ella Lacey PhD, Carbondale Illinois

Gerald Van Belle PhD, University of Washington School of Public Health & Community Medicine

Richard Penn MD, Mount Sinai Medical Center

Gustavo Roman MD, University of Texas Health Science School of Medicine San Antonio

Jerry Wolinsky MD, University of Texas Houston Health

Sandra Titus PhD, FDA

 

 

Tel: 301-571-2388 | Fax: 301-897-8050 | Email: infor@yalepharma.com

1996-2010 Yale Pharmaceutical Research Institute. All Rights Reserved.